eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | hepatitis c |
| Symptom | |hepatocellular carcinoma |
| Sentences | 117 |
| PubMedID- 25373121 | Are selective serotonin reuptake inhibitors associated with hepatocellular carcinoma in patients with hepatitis c. |
| PubMedID- 22966320 | Development of hepatocellular carcinoma in patients with chronic hepatitis c more than 10 years after sustained virological response to interferon therapy. |
| PubMedID- 26469163 | Methods: thirty consecutive cases of percutaneous arterial chemoembolization for hepatocellular carcinoma with hepatitis c-related cirrhosis(male, 23; female, 7; age, 74+/-5.9; weight, 62.7+/-12.3 kg; child-pugh a, 23; child-pugh b, 7)were analyzed retrospectively. |
| PubMedID- 25559682 | The aim of the present study was to evaluate wfa(+) -m2bp as a predictor of hepatocellular carcinoma (hcc) development in patients with chronic hepatitis c. |
| PubMedID- 26424404 | Background: end-stage liver disease and hepatocellular carcinoma due to hepatitis c virus (hcv) co-infection are increasingly common causes of death among hiv-infected individuals. |
| PubMedID- 21170963 | Obesity and metabolic syndrome are recognized risk factors for development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c (chc). |
| PubMedID- 21963516 | To identify the genetic susceptibility factor(s) for hepatitis c virus-induced hepatocellular carcinoma (hcv-induced hcc), we conducted a genome-wide association study using 432,703 autosomal snps in 721 individuals with hcv-induced hcc (cases) and 2890 hcv-negative controls of japanese origin. |
| PubMedID- 23426277 | Association of interleukin-28b genotype and hepatocellular carcinoma recurrence in patients with chronic hepatitis c. |
| PubMedID- 19879972 | Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis c virus-related cirrhosis. |
| PubMedID- 21374690 | Previous studies have suggested that prior exposure to hepatitis b virus (hbv) infection may increase the risk of development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c. |
| PubMedID- 21133598 | Comparison of serum survivin and alpha fetoprotein in egyptian patients with hepatocellular carcinoma associated with hepatitis c viral infection. |
| PubMedID- 24409059 | Aim: to study the potential association between hepatocellular carcinoma (hcc) in patients with chronic hepatitis c (chc), cirrhosis and latent hepatitis b (lhb) infection, defined as the absence of detectable serum hepatitis b surface antigen (hbsag) and the presence of hepatitis b core antibody (hbcab). |
| PubMedID- 22414050 | Aim: the role of interferon (ifn) therapy on prevention of hepatocellular carcinoma (hcc) in patients with hepatitis c virus (hcv)-related cirrhosis remains controversial. |
| PubMedID- 21526141 | We report a case of hepatocellular carcinoma (hcc) with chronic hepatitis c virus infection successfully treated with percutaneous radiofrequency ablation (rfa) under live four-dimensional (4d) echo guidance. |
| PubMedID- 23849467 | The present cross-sectional study investigated 12 perfluoroalkyl substances (pfass) in serum (n=79) and liver (n=66) samples from patients who had undergone liver transplantation for a range of conditions, such as hepatocellular carcinoma (hcc), cirrhosis due to chronic hepatitis c viral infection (hcv), both hcc and hcv, amyloidosis or acute liver failure. |
| PubMedID- 23860735 | Genetic variation near interleukin 28b and the risk of hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 20404016 | The incidence of hepatocellular carcinoma is rising due to alcohol drinking, hepatitis c viral infection and metabolic syndrome. |
| PubMedID- 21499248 | To identify the genetic susceptibility factor(s) for hepatitis c virus-induced hepatocellular carcinoma (hcv-induced hcc), we conducted a genome-wide association study using 432,703 autosomal snps in 721 individuals with hcv-induced hcc (cases) and 2,890 hcv-negative controls of japanese origin. |
| PubMedID- 24367218 | Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis c virus. |
| PubMedID- 25667487 | Patients and methods: serum samples were collected preoperatively from 125 patients with hepatocellular carcinoma associated with hepatitis c virus infection who underwent curative hepatectomy. |
| PubMedID- 25559606 | The effect of hiv viral control on the incidence of hepatocellular carcinoma in veterans with hepatitis c and hiv coinfection. |
| PubMedID- 24662676 | Given the role of hepatocellular cd81 in hcv infection and the association of chronic hepatitis c with hepatocellular carcinoma (hcc) there is a growing interest in studying the function of cd81 in hepatocytes. |
| PubMedID- 25788045 | Methods: serum ferritin was measured in 487 chronic hepatitis c patients without history of hepatocellular carcinoma (hcc) after excluding patients in phlebotomy, those with overt chronic gastrointestinal bleeding and those who achieved sustained virological response before enrollment. |
| PubMedID- 22743730 | Case report: a 60 year-old man underwent ldlt for hepatitis c virus-related cirrhosis with hepatocellular carcinoma. |
| PubMedID- 26301052 | hepatitis c infection can lead to cirrhosis and hepatocellular carcinoma and it is an important cause of mortality and morbidity. |
| PubMedID- 23844083 | Protein kinase r modulates c-fos and c-jun signaling to promote proliferation of hepatocellular carcinoma with hepatitis c virus infection. |
| PubMedID- 23509319 | Statins and the risk of hepatocellular carcinoma in patients with hepatitis c virus infection. |
| PubMedID- 25469280 | Dm with insulin resistance is a risk factor for hepatocellular carcinoma (hcc) in patients with hepatitis c virus (hcv) infection. |
| PubMedID- 23404391 | Repeat hepatectomies for hepatic malignant lymphoma and hepatocellular carcinoma associated with chronic hepatitis c: report of a case. |
| PubMedID- 25657603 | In a recent report from our institution, we identified over a three-year period 3% (9/298) of ltx patients who developed severe hf after ltx.62 in these nine patients, etiology of liver failure was hepatitis c with hepatocellular carcinoma in four, hemochromatosis in four (with one showing evidence of iron deposition in the heart on biopsy), and one with primary biliary cirrhosis. |
| PubMedID- 22911171 | Methods: thirty-eight patients who underwent hepatectomy for hepatocellular carcinoma (hcc) with hepatitis c virus infection were included. |
| PubMedID- 26045707 | Conclusions: sustained virological response can reduce all-cause mortality and the incidence of hepatocellular carcinoma of patients with hepatitis c. |
| PubMedID- 23547582 | Screening for hepatocellular carcinoma in patients with hepatitis c virus infection. |
| PubMedID- 21331763 | Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 21224684 | We performed transarterial chemoembolization (tace) on the 67-year-old man who had hepatectomy for hepatocellular carcinoma with hepatitis c, recurrence in the liver and lymph nodes.the metastasis in lymph node did not show a clear increase until dying, and tace showed the possibility of one treatment method to the metastasis in lymph node of the hepatocellular carcinoma. |
| PubMedID- 21234423 | A 73-year-old female with history of hepatocellular carcinoma due to long-standing hepatitis c, presented to the emergency center with a sudden syncopal episode at home. |
| PubMedID- 22695885 | Background: there is limited literature on hepatocellular carcinoma (hcc) in patients with chronic hepatitis c virus (hcv) infection in the absence of cirrhosis. |
| PubMedID- 22899800 | A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis c after sustained response to pegylated interferon and ribavirin combination therapy. |
| PubMedID- 21286221 | A 72-year-old japanese man underwent partial resection of the liver for hepatocellular carcinoma associated with hepatitis c viral infection. |
| PubMedID- 26519622 | The updated model: an adjusted serum alpha-fetoprotein-based algorithm for hepatocellular carcinoma detection with hepatitis c virus-related cirrhosis. |
| PubMedID- 22096937 | Antiviral treatment reduces risk of hepatocellular carcinoma in patients with hepatitis c virus-related chronic hepatitis and cirrhosis. |
| PubMedID- 22013259 | The first patient was a 45-year-old male hepatitis c related cirrhosis with hepatocellular carcinoma, child grade c, with refractory ascites, coagulopathy and mild hepatorenal syndrome. |
| PubMedID- 24632756 | The serum level of vegf has potential to be a useful predictor of the presence of hepatocellular carcinoma in patients with hepatitis c virus (hcv)-related liver cirrhosis, while serum levels of afp and vegf can predict tumor type and vascular invasion, respectively25. |
| PubMedID- 26140089 | Aim: to evaluate the downstaging rates in hepatitis c virus-patients with hepatocellular carcinoma (hcc), treated with degradable starch microspheres transcatheter arterial chemoembolization (dsm-tace), to reach new-milan-criteria (nmc) for transplantation. |
| PubMedID- 22439008 | stated that phlebotomy therapy may potentially lower the risk of progression to hepatocellular carcinoma (hcc) in patients with hepatitis c virus infection. |
| PubMedID- 23463401 | hepatocellular carcinoma in patients with chronic hepatitis c virus infection in the asia-pacific region. |
| PubMedID- 23689989 | Il28b minor allele is associated with a younger age of onset of hepatocellular carcinoma in patients with chronic hepatitis c virus infection. |
| PubMedID- 20731020 | hepatocellular carcinoma in patients with chronic hepatitis c virus infection without cirrhosis. |
| PubMedID- 21537363 | A 78-year-old male who experienced multiple recurrences of hepatocellular carcinoma (hcc) with hepatitis c virus (hcv)-related cirrhosis underwent transcatheter arterial chemoembolization and ablation and survived for more than 10 years. |
| PubMedID- 23099187 | Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis c: a prospective, multicenter study. |